全胰腺切除术后继发性糖尿病的血糖控制与变异性:连续葡萄糖监测评估
本研究为病例对照研究,纳入10例全胰腺切除(PX)患者、10例HbA1c匹配的1型糖尿病(T1D)患者及10名健康对照,均使用每日多次胰岛素注射,进行连续12天连续葡萄糖监测(CGM)。结果显示PX组与T1D组HbA1c相似,但PX组CONGA60min更高、平均血糖更高、高于范围时间更多,而低于范围时间两组无差异。
要点
- PX患者与HbA1c匹配的T1D患者相比,CGM评估的血糖变异性更高
- PX组平均血糖和高于范围时间显著高于T1D组
- 两组低于范围时间无显著差异(P=0.065)
核心结论
- 全胰腺切除术后继发性糖尿病患者经CGM评估的血糖变异性(CONGA60min)和高于范围时间均高于HbA1c匹配的1型糖尿病患者。
研究设计与样本
- 病例对照研究,纳入10例全胰腺切除(PX)患者、10例HbA1c匹配的1型糖尿病(T1D)患者和10名性别、年龄、BMI匹配的健康对照。
- 所有患者接受每日多次胰岛素注射,使用Medtronic MiniMed iPro 2进行连续12天连续葡萄糖监测(CGM)。
主要发现
- PX组与T1D组HbA1c水平相似。
- PX组CONGA60min高于T1D组(均值[SEM]:9.5[0.3] vs 8.3[0.2] mmol/L,P<0.003)。
- PX组平均血浆葡萄糖高于T1D组(10.6[0.9] vs 9.0[0.9] mmol/L,P<0.001)。
- 两组血浆葡萄糖变异系数和平均血浆葡萄糖标准差相似。
- PX组高于范围时间高于T1D组(51.4[3.3] vs 37.6[1.9]%,P<0.001),低于范围时间两组无差异(2.3[0.8] vs 4.5[0.8]%,P=0.065)。
关键数值与推荐
- PX组平均年龄64.3[SEM 9.8]岁,BMI 34.4[5.0] kg/m2,糖尿病病程3[2.8]年。
- T1D组平均年龄63.9[8.6]岁,BMI 24.6[3.1] kg/m2,糖尿病病程22[4]年。
临床怎么用
- 对全胰腺切除术后糖尿病患者应关注血糖变异性及高于范围时间,CGM可用于评估血糖控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The extent of the glycemic variability in diabetes secondary to total pancreatectomy is not fully understood. OBJECTIVE: To evaluate glycemic variability in totally pancreatectomized (PX) patients and compare it to glycemic variability in hemoglobin A1c (HbA1c)-matched patients with long-standing type 1 diabetes (T1D). DESIGN: A case-control study was performed. SETTING: Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. PATIENTS OR OTHER PARTICIPANTS: Ten PX patients (mean [SEM]: age 64.3 [9.8] years; body mass index (BMI) 34.4 [5.0] kg/m2; duration of diabetes 3 [2.8] years), 10 HbA1c-matched patients with T1D (63.9 [8.6] years; 24.6 [3.1] kg/m2; 22 [4] years), and 10 gender-, age-, and BMI-matched healthy controls. All patients were managed on multiple daily injections of insulin. INTERVENTION: Continuous glucose monitoring (CGM) (Medtronic MiniMed iPro 2) during 12 consecutive days. MAIN OUTCOME MEASURES: Glycemic variability. RESULTS: HbA1c levels were similar in the PX group and the T1D group. The PX group had greater continuous overall net glycemic action per 60 minutes (CONGA60 min) compared with the T1D group (mean [SEM]: 9.5 [0.3] vs 8.3 [0.2] mmol/L, P < 0.003) and mean plasma glucose values were higher in the PX group (10.6 [0.9] vs 9.0 [0.9] mmol/L, P < 0.001), whereas coefficient of variation for plasma glucose and standard deviation of mean plasma glucose, respectively, were similar in the 2 groups. Time spent below range was not different between the PX and the T1D group (2.3 [0.8] vs 4.5 [0.8]%, P = 0.065), whereas time spent above range was higher in the PX group (51.4 [3.3] vs 37.6 [1.9]%, P < 0.001). CONCLUSIONS: CGM-assessed glycemic variability showed higher CONGA60 min and time spent above range in our PX patients compared with HbA1c-matched T1D patients. This study is registered at www.ClinicalTrials.gov (NCT02944110).
引用
- Juel CTB, Dejgaard TF, Hansen CP, et al. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2021. PMID: 33053154. doi:10.1210/clinem/dgaa731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。